September 26, 2016 — Zitter Health Insights, a business intelligence firm serving life science
companies, specialty pharmacies and managed healthcare organizations focused on optimizing
patient access to pharmaceuticals, today announced that founder and CEO Mark Zitter will step
down from his leadership role. Current President John Monahan will be appointed CEO of the
business upon Zitter’s transition to Chairman.
“Based on his many years of success leading health information businesses, I am very confident
that John Monahan is the right leader for Zitter Health Insights,” said Zitter. “John has a long
and accomplished history as a results-driven leader. He knows how to focus a business on
growth, how to successfully create products that meet customer needs, and how to get the
best out of everyone who works with and for him.”
Monahan will assume the CEO role on January 1, 2017. Zitter will continue as Chairman of the
Zitter Health Insights Board, and will remain a major shareholder in the privately-held business.
Mark Zitter founded the business as The Zitter Group in 1989, and initially produced
conferences and conducted custom research on managed care trends. The business was
renamed Zitter Health Insights to reflect its transition to a syndicated research and business
intelligence firm working with life science companies, payers, pharmacy benefit managers,
specialty pharmacies, and other healthcare stakeholders.
“It is a great honor to be entrusted with this business, which has long been viewed as a
respected and expert voice in the healthcare industry thanks to the leadership and insight of
Mark Zitter,” said Monahan. “We are grateful for Mark’s commitment to this business, and
enthusiastic about the future of Zitter Health Insights.”
Monahan joined Zitter Health Insights in 2014, having served most recently as Senior Vice
President of Corporate Services for Barnabas Health. Prior to that, he was President & CEO of
Wolters Kluwer Health’s Global Pharmaceutical Solutions Division. He also held a number of
leadership roles with other health information businesses, including CEO of IC Axon and
President and other roles at Innovex Inc, a division of Quintiles.
– # –
Zitter Health Insights (ZHI) combines focused expertise with syndicated subscription research to
optimize patient access to pharmaceuticals. Since 1989, ZHI has provided insights to help life science
companies, specialty pharmacies, and managed care organizations get the right drugs to the right